The Company Strengthens Balance Sheet to Support Proposed Merger, Takes Strides to Regaining Nasdaq Listing Compliance DENVER, CO / ACCESS Newswire / July 15, 2026 / SOBR Safe, Inc. (NASDAQ:SOBR) (&#34;SOBRsafe&#34; or

<p><i><strong>The Company Strengthens Balance Sheet to Support Proposed Merger, Takes Strides to Regaining Nasdaq Listing Compliance</strong></i></p> <p><strong id="dateline">DENVER, CO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / July 15, 2026 / </strong>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/SOBR">SOBR</a>) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares originally issued in December 2025, having an exercise price of $1.30 per share, at a reduced exercise price of $1.05 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292709).</p><p>H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.</p><p>In consideration for the immediate exercise of the warrants for cash and the payment of an additional $0.125 per new unregistered warrant (additional $590,162 in the aggregate, which are included in the gross proceeds to the Company), the Company will issue new unregistered Series E warrants to purchase up to 2,360,648 shares of common stock and new unregistered Series F warrants to purchase up to 2,360,648 shares of common stock. The Series E new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire five years after the effective date of the Resale Registration Statement (as defined below). The Series F new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire twenty-four months after the effective date of the Resale Registration Statement (as defined below).</p><p>The aggregate gross proceeds to the Company from the offering are expected to be approximately $3.1 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about July 16, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.</p><p>The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").</p><p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p><p><strong>About SOBRsafe&#8482;</strong></p><p>Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit <a rel="nofollow" href="https://pr.report/nscy">www.sobrsafe.com</a>.</p><p><strong>Safe Harbor Statement</strong></p><p>Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering, and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this news release. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "will," "would" or other similar expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at <a rel="nofollow" href="https://pr.report/nscz">www.sec.gov</a>.</p><p><strong>Company Contact:</strong></p><p><a rel="nofollow" href="mailto:IR@sobrsafe.com">IR@sobrsafe.com</a></p><p><strong>Investor Relations Contact:</strong></p><p>Scott Liolios or Taylor Stadeli<br/>Gateway Group<br/>949-574-3860<br/><a rel="nofollow" href="mailto:SOBR@gateway-grp.com">SOBR@gateway-grp.com</a></p><p><strong>SOURCE:</strong> SOBR Safe, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/business-and-professional-services/sobrsafe-announces-exercise-of-warrants-for-3.1-million-gross-pr-1191665'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1191665" width="0" height="0"/>

SOBR

SOBRsafe Announces Exercise of Warrants for $3.1 Million Gross Proceeds

SOBRsafe raises $3.1M via warrant exercise to support merger, Nasdaq listing

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>The Company Strengthens Balance Sheet to Support Proposed Merger, Takes Strides to Regaining Nasdaq Listing Compliance DENVER, CO / ACCESS Newswire / July 15, 2026 / SOBR Safe, Inc. (NASDAQ:SOBR) (&amp;#34;SOBRsafe&amp;#34; or</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>SOBRsafe announced definitive agreements to immediately exercise warrants for 2.36 million shares at $1.05 and to issue new Series E/F warrants, targeting roughly $3.1 million in gross proceeds. The funds are intended to strengthen the balance sheet to back a proposed merger and support Nasdaq listing compliance, with closing around July 16, 2026. While this improves liquidity, potential share dilution could temper near-term upside.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>SOBRsafe exercises warrants for 2.36M shares at $1.05.</li><li>New Series E and F warrants issued, exercisable immediately.</li><li>Gross proceeds about $3.1M; funds for working capital.</li><li>Proceeds bolster balance sheet for merger and Nasdaq compliance.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>SOBR Safe, Inc. (SOBR)</strong>: Issuer; financing and Nasdaq-compliance update; warrants activity and merger implications.</li><li><strong>H.C. Wainwright &amp; Co. (N/A)</strong>: Exclusive placement agent; enables private placement; not a public-traded counterparty.</li><li><strong>Gateway Group (N/A)</strong>: Investor relations contact; facilitates communication with investors; not a direct price driver.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. The article centers on financing activity tied to a potential merger and Nasdaq-compliance efforts, key drivers of near-term sentiment and valuation for SOBR.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Warrant exercise secures ~ $3.1M gross proceeds, impacting dilution.</li><li>Closing targeted around July 16, 2026; outcome depends on merger and regulatory milestones.</li><li>Nasdaq listing compliance progress remains a key near-term driver.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Aggregate warrants: 2,360,648 shares originally issued December 2025.</li><li>Original exercise price: $1.30; immediate exercise at $1.05 for the warrant.</li><li>New Series E/F warrants: exercise price $1.30; Series E five-year, Series F 24 months.</li><li>Aggregate gross proceeds: approximately $3.1 million before fees.</li><li>Closing date expected on or about July 16, 2026.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term catalysts from financing and Nasdaq progress could spark a relief rally, but dilution may cap upside.</p>
  </section>
</section>


<p><i><strong>The Company Strengthens Balance Sheet to Support Proposed Merger, Takes Strides to Regaining Nasdaq Listing Compliance</strong></i></p> <p><strong id="dateline">DENVER, CO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / July 15, 2026 / </strong>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/SOBR">SOBR</a>) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares originally issued in December 2025, having an exercise price of $1.30 per share, at a reduced exercise price of $1.05 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292709).</p><p>H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.</p><p>In consideration for the immediate exercise of the warrants for cash and the payment of an additional $0.125 per new unregistered warrant (additional $590,162 in the aggregate, which are included in the gross proceeds to the Company), the Company will issue new unregistered Series E warrants to purchase up to 2,360,648 shares of common stock and new unregistered Series F warrants to purchase up to 2,360,648 shares of common stock. The Series E new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire five years after the effective date of the Resale Registration Statement (as defined below). The Series F new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire twenty-four months after the effective date of the Resale Registration Statement (as defined below).</p><p>The aggregate gross proceeds to the Company from the offering are expected to be approximately $3.1 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about July 16, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.</p><p>The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").</p><p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p><p><strong>About SOBRsafe&#8482;</strong></p><p>Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit <a rel="nofollow" href="https://pr.report/nscy">www.sobrsafe.com</a>.</p><p><strong>Safe Harbor Statement</strong></p><p>Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering, and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this news release. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "will," "would" or other similar expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at <a rel="nofollow" href="https://pr.report/nscz">www.sec.gov</a>.</p><p><strong>Company Contact:</strong></p><p><a rel="nofollow" href="mailto:IR@sobrsafe.com">IR@sobrsafe.com</a></p><p><strong>Investor Relations Contact:</strong></p><p>Scott Liolios or Taylor Stadeli<br/>Gateway Group<br/>949-574-3860<br/><a rel="nofollow" href="mailto:SOBR@gateway-grp.com">SOBR@gateway-grp.com</a></p><p><strong>SOURCE:</strong> SOBR Safe, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/business-and-professional-services/sobrsafe-announces-exercise-of-warrants-for-3.1-million-gross-pr-1191665'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1191665" width="0" height="0"/>

SOBRsafe announced definitive agreements to immediately exercise warrants for 2.36 million shares at $1.05 and to issue new Series E/F warrants, targeting roughly $3.1 million in gross proceeds. The funds are intended to strengthen the balance sheet to back a proposed merger and support Nasdaq listing compliance, with closing around July 16, 2026. While this improves liquidity, potential share dilution could temper near-term upside.

SOBRsafe Announces Exercise of Warrants for $3.1 Million Gross Proceeds

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News